| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 326.071 | 613.677 | 442.425 | 349.476 |
| Total Income - EUR | - | - | - | - | - | 0 | 342.713 | 601.309 | 444.804 | 349.751 |
| Total Expenses - EUR | - | - | - | - | - | 3.033 | 255.527 | 475.342 | 465.262 | 407.523 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -3.033 | 87.185 | 125.967 | -20.457 | -57.772 |
| Net Profit/Loss - EUR | - | - | - | - | - | -3.033 | 82.219 | 120.670 | -24.231 | -67.473 |
| Employees | - | - | - | - | - | 0 | 2 | 4 | 3 | 2 |
Check the financial reports for the company - Molecular Genomics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 4.506 | 30.354 | 94.995 | 103.416 | 107.141 |
| Current Assets | - | - | - | - | - | 23.093 | 133.674 | 147.269 | 129.307 | 87.293 |
| Inventories | - | - | - | - | - | 0 | 20.543 | 77.227 | 31.477 | 11.344 |
| Receivables | - | - | - | - | - | 0 | 56.651 | 43.954 | 61.832 | 47.345 |
| Cash | - | - | - | - | - | 23.093 | 56.481 | 26.088 | 35.997 | 28.604 |
| Shareholders Funds | - | - | - | - | - | 9.371 | 91.383 | 209.114 | 158.027 | 89.671 |
| Social Capital | - | - | - | - | - | 12.404 | 12.129 | 12.167 | 12.130 | 12.062 |
| Debts | - | - | - | - | - | 18.228 | 72.968 | 34.043 | 79.137 | 105.831 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Molecular Genomics S.r.l.